Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.
about
Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitisA Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.Amdinocillin: a novel penicillin. Antibacterial activity, pharmacology and clinical use.Influence of food on bioavailability of amdinocillin pivoxil.Penicillins--new insights into their mechanisms of activity and clinical use.Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillinExperimental endocarditis caused by Streptococcus sanguis: single and combined antibiotic therapy.Lysis of Escherichia coli by beta-lactams which bind penicillin-binding proteins 1a and 1b: inhibition by heat shock proteins.Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agentsCollaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillinEmerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria.Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam).In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam.Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.Comparison of pivmecillinam and cephradine in bacteriuria in pregnancy and in acute urinary tract infection.Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.Activity of mecillinam alone and in combination with other beta-lactam antibiotics.Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis.Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants.Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases.In vitro activity and beta-lactamase stability of a monobactam, SQ 26,917, compared with those of aztreonam and other agents.Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.The combination of pivampicillin and pivmecillinam versus pivampicillin alone in the treatment of acute pyelonephritis.Pivmecillinam in the treatment of therapy resistant urinary tract infections. A comparison with pivmecillinam, pivampicillin and their combination.Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review.
P2860
Q30450457-503173CC-ABEC-4987-8525-029C1F44CDD4Q33979272-473932DD-63C8-4D98-BDF1-D153B61FD229Q34193447-76A51535-4A5B-4FB6-8D4D-BCE780ED5E92Q35301199-63C30384-CDC7-4E1E-8DFD-4A78BF193DF7Q35651608-2A64F51C-3E0E-4C0C-A9C5-4F339A347F35Q35668885-4988FAA1-2273-408C-9395-64DFC0C2855EQ35670841-515EA923-E919-4FF5-8C7E-B42B10D786B6Q36147941-D9BD991C-3113-47B7-94E2-7A94727EB1A5Q36170427-872962AC-5441-49B4-AD8F-57C2741BFBFCQ37215174-6BB745C7-ABD0-41D5-803B-032EE28B1822Q38143651-193D888B-7E5E-422F-B9B1-E4C87D698C87Q39832604-B0D93A94-0810-4C5D-8A73-447FDE44F9DBQ39851736-4201D4EB-098A-4A57-B676-649E7E99F0EAQ39856404-EF921DBE-A9F9-4496-A6B7-3241E8665CCBQ39856429-9B490264-3243-4CFA-95FB-531BDCE50514Q40248770-83196F09-6ECF-44AF-96D3-5F4D107E8968Q40287521-28872298-6A46-4F05-8DD7-DF933D3E5FFBQ40618526-3506F512-787B-44C5-B1D3-E7C08376BE6BQ40621575-5ECFAEB1-0FA2-4C7E-8270-F3A7B8D24C87Q40690530-D97BB966-8B79-4E42-BC8D-DFE3C3B096F1Q40916464-5153DAD9-2B3D-417B-8BA7-1E6B3825897DQ41031284-03A05EBD-A2AC-494D-961F-B83B384357C6Q41951838-D8223650-A90F-4CCD-A588-08F2B83A555CQ42926948-E5A3A1B3-B607-4557-82DC-2136500D384EQ54436436-CD27375B-6D8E-4F07-A77A-73392A00FC53Q54563449-C53BE185-E45B-4E57-98EB-2C6712958D65Q55113256-E825F714-805E-4EFD-8FF1-9EB875BCA35A
P2860
Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Synergy of mecillinam, a beta- ...... with beta-lactam antibiotics.
@en
type
label
Synergy of mecillinam, a beta- ...... with beta-lactam antibiotics.
@en
prefLabel
Synergy of mecillinam, a beta- ...... with beta-lactam antibiotics.
@en
P2860
P356
P1476
Synergy of mecillinam, a beta- ...... with beta-lactam antibiotics.
@en
P2093
P2860
P304
P356
10.1128/AAC.10.3.535
P407
P577
1976-09-01T00:00:00Z